| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'Dotarem®' found in 1 term [] and 3 definitions []
| 1 - 4 (of 4) Result Pages : [1] | | | | | | |
Dotarem® | |
| |
|
Drug Information and Specification
T1, Predominantly positive enhancement
PHARMACOKINETIC
Intravascular, extracellular, renal excretion
DOSAGE
0.1 mmol/kg / 0.2mL/kg
PREPARATION
Finished product
INDICATION
Neuro/whole body
DEVELOPMENT STAGE
For sale
PRESENTATION
Vials of 5, 10, 15, 20mL Pre-filled syringes of 15 and 20 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT STAGE
DISTRIBUTOR
France, Switzerland
Artirem®
for sale
| | | | | • Share the entry 'Dotarem®': | | | | Further Reading: | | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
Artirem®, the arthrography-specific contrast agent for MRI is a dilute form of Dotarem® with a less concentration of Gd (1:200).
Artirem® has to be injected directly into the joints for better visualization and delimitation, of the ligament and tendon structures in particular.
Drug Information and Specification
T1, Predominantly positive enhancement
PHARMACOKINETIC
Intravascular, extracellular, renal excretion
CONCENTRATION
0,0025 mmol/ml
PREPARATION
Finished product
DEVELOPMENT STAGE
For sale
PRESENTATION
Pre-filled syringes of 20 mL
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
Distribution Information
TERRITORY
TRADE NAME
DEVELOPMENT STAGE
DISTRIBUTOR
France, Switzerland
Artirem®
for sale
| | | | • View the DATABASE results for 'Artirem®' (4).
| | | | Further Reading: | News & More:
|
|
| |
| | | | | |
| |
|
(Gd) Gadolinium is a Lanthanide element that is paramagnetic in its trivalent state.
This paramagnetic substance is used for MR imaging because of the effect of strongly decreasing the T1 relaxation times of the tissues to which gadolinium has access. When injected during magnetic resonance imaging, gadolinium will tend to change signal intensities by shortening the T1 time in its surroundings.
The relaxivity of gadolinium is an important measure of its efficacy, which is dependent on the chemical properties of the complex. The gadolinium ion cannot be used in its chloride, sulfate, or acetate forms because of poor tolerance and low solubility in water in the neutral pH range. Although toxic by itself, gadolinium can be given safely in a chelated form such as DTPA, that still retains much of its strong effect on relaxation times ( relaxivity).
See also Dotarem®, Gadovist®, MultiHance®, Omniscan®, OptiMARK®, and Contrast Agents, the info sheet gives an overview and more in-dept information about different types of MRI contrast agents. | | | | | | • View the DATABASE results for 'Gadolinium' (66).
| | | • View the NEWS results for 'Gadolinium' (17).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
MRI Contrast Agents:
Contact Information
MAIL
Guerbet
Boite postale 50400
95943 Roissy
Charles de Gaulle Cedex
FRANCE
| | | | • View the DATABASE results for 'Guerbet S.A.' (7).
| | | • View the NEWS results for 'Guerbet S.A.' (2).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | |
| | 1 - 4 (of 4) Result Pages : [1] |
| |
|
| |
| Look Ups |
| |